Encompass Health Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	5,935	5,373	4,801	4,349	4,015
Revenue Growth (YoY)	10.46%	11.91%	10.41%	8.31%	12.58%
Cost of Revenue	3,370	3,140	2,818	2,595	2,312
Gross Profit	2,565	2,233	1,983	1,753	1,703
Selling, General & Admin	295.2	266.5	258	209	228.5
Other Operating Expenses	888.7	792.2	719.1	670.4	595.9
Operating Expenses	1,512	1,358	1,251	1,123	1,044
Operating Income	1,053	874.9	731.8	630.2	659.4
Interest Expense	-123.2	-137.4	-143.5	-175.7	-164.3
Earnings From Equity Investments	4.3	3	3.2	2.9	3.4
Other Non Operating Income (Expenses)	18.8	20.1	15.7	-5.2	7.5
EBT Excluding Unusual Items	953	760.6	607.2	452.2	506
Merger & Restructuring Charges	-	-10.4	-	-	-
Other Unusual Items	-	-0.6	-	-1.4	-1
Pretax Income	953	749.6	607.2	450.8	505
Income Tax Expense	192.9	150.2	132.2	100.1	101.9
Earnings From Continuing Operations	760.1	599.4	475	350.7	403.1
Earnings From Discontinued Operations	-1	-2.8	-12	13.9	112.3
Net Income to Company	759.1	596.6	463	364.6	515.4
Minority Interest in Earnings	-192.9	-140.9	-111	-93.6	-103.2
Net Income	566.2	455.7	352	271	412.2
Preferred Dividends & Other Adjustments	-	2.8	2.4	1.2	1.8
Net Income to Common	566.2	452.9	349.6	269.8	410.4
Net Income Growth	24.25%	29.46%	29.89%	-34.26%	45.04%
Shares Outstanding (Basic)	101	100	100	99	99
Shares Outstanding (Diluted)	102	102	101	100	100
Shares Change (YoY)	-	0.89%	0.90%	0.20%	0.40%
EPS (Basic)	5.63	4.53	3.51	2.72	4.15
EPS (Diluted)	5.54	4.46	3.47	2.70	4.11
EPS Growth	24.25%	28.32%	28.73%	-34.39%	44.46%
Free Cash Flow	439.2	360.3	267.7	121.7	170.1
Free Cash Flow Per Share	4.30	3.52	2.64	1.21	1.70
Dividend Per Share	0.720	0.640	0.600	0.860	1.120
Dividend Growth	12.50%	6.67%	-30.23%	-23.21%	-
Gross Margin	43.21%	41.56%	41.30%	40.32%	42.43%
Operating Margin	17.74%	16.28%	15.24%	14.49%	16.42%
Profit Margin	9.54%	8.43%	7.28%	6.20%	10.22%
Free Cash Flow Margin	7.40%	6.71%	5.58%	2.80%	4.24%
EBITDA	1,381	1,175	1,006	873.8	879
EBITDA Margin	23.27%	21.86%	20.95%	20.09%	21.89%
D&A For EBITDA	327.9	299.6	273.9	243.6	219.6
EBIT	1,053	874.9	731.8	630.2	659.4
EBIT Margin	17.74%	16.28%	15.24%	14.49%	16.42%
Effective Tax Rate	20.24%	20.04%	21.77%	22.20%	20.18%
Advertising Expenses	-	5.8	6.1	6.3	5.6

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q